Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Letter to the Editor
Page 29
Recently published articles about
Letter to the Editor
PCC
Letter to the Editor
Nobody Told Me!
February 9, 2017
Find out what led this veteran to consider suicide when he received a diagnosis of obstructive sleep apnea. See the importance of communication, because even seemingly small or simple...
Piyush Das
PCC
Letter to the Editor
When the Solution Causes a Bigger Problem
February 2, 2017
In this case of cannabis-induced psychosis, the patient experienced worsening psychosis the more he was treated with antipsychotics. And then seizures? Read how the cycle was ended.
Ryan Webler
,
Tarique Perera
PCC
Letter to the Editor
Paliperidone-Induced Meige Syndrome
January 26, 2017
Meige syndrome is a focal oral facial dystonia involving symmetrical blepharospasm and oromandibular dystonia. The typical symptom of the disorder is difficulty keeping the eyelids open. This report highlights...
João Gama Marques
JCP
Letter to the Editor
Drs Ionescu and Cusin Reply
January 25, 2017
Cristina Cusin
,
Dawn F. Ionescu
JCP
Letter to the Editor
Reduction in Suicidal Ideation Following Repeated Doses of Intravenous Ketamine?
January 25, 2017
Robert A. Schoevers
,
Sanne Y. Apeldoorn
,
Marrit K. de Boer
PCC
Letter to the Editor
Aripiprazole and Impulse-Control Disorders
January 12, 2017
The US Food and Drug Administration released a safety announcement regarding aripiprazole and the induction of impulse-control disorders. Read the case of a man with schizophrenia who experienced pathological...
Prashant Tibrewal
,
Rohan Dhillon
,
Tarun Bastiampillai
, et al
«
1
…
27
28
29
30
31
…
174
»